The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?

Journal of Neurosurgery

Volumn 124, Issue 4, 2016, Pages 977-988

  Li, Yan Michael ^a,b   Suki, Dima ^a   Hess, Kenneth ^a   Sawaya, Raymond ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Extent of resection; Glioblastoma multiforme; Oncology; Prognosis; Survival

Indexed keywords

TEMOZOLOMIDE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN REGION; BRAIN SURGERY; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MEDIAN SURVIVAL TIME; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE EDEMA; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SPEECH DISORDER; SURVIVAL TIME; TUMOR VOLUME; VERY ELDERLY; VISUAL DISORDER; ADOLESCENT; BRAIN NEOPLASMS; CHILD; COHORT ANALYSIS; KAPLAN MEIER METHOD; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; NEUROSURGERY; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; PRESCHOOL CHILD; PROCEDURES; PROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; NEUROSURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84975258063     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2015.5.JNS142087     Document Type: Article

References (28)

1. Altman DG, Lausen B, Sauerbrei W, Schumacher M: Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86:829-835, 1994
2. Bernstein JJ, Goldberg WJ, Laws ER Jr, Conger D, Morreale V, Wood LR: C6 glioma cell invasion and migration of rat brain after neural homografting: ultrastructure. Neurosur-gery 26:622-628, 1990
3. Burger PC, Dubois PJ, Schold SC Jr, Smith KR Jr, Odom GL, Crafts DC, et al: Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblas-toma multiforme. J Neurosurg 58:159-169, 1983
4. Burger PC, Heinz ER, Shibata T, Kleihues P: Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 68:698-704, 1988
5. Cerame MA, Guthikonda M, Kohli CM: Extraneural metas-tases in gliosarcoma: a case report and review of the literature. Neurosurgery 17:413-418, 1985
6. Choucair AK, Levin VA, Gutin PH, Davis RL, Silver P, Edwards MS, et al: Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas. J Neurosurg 65:654-658, 1986
7. Dolecek TA, Propp JM, Stroup NE, Kruchko C: CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol 14 (Suppl 5):v1-v49, 2012
8. Earnest F I V, Kelly PJ, Scheithauer BW, Kall BA, Cascino TL, Ehman RL, et al: Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereo-tactic biopsy. Radiology 166:823-827, 1988
9. Ebos JM, Lee CR, Kerbel RS: Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy. Clin Cancer Res 15:5020-5025, 2009
10. Greene GM, Hitchon PW, Schelper RL, Yuh W, Dyste GN: Diagnostic yield in CT-guided stereotactic biopsy of gliomas. J Neurosurg 71:494-497, 1989
11. Hochberg FH, Pruitt A: Assumptions in the radiotherapy of glioblastoma. Neurology 30:907-911, 1980
12. Ibayashi N, Herman MM, Boyd JC, Rubinstein LJ: Relation-ship of invasiveness to proliferating activity and to cyto-skeletal protein production in human neuroepithelial tumors maintained in an organ culture system: use of human cortex and dura as supporting matrices. Neurosurgery 26:629-637, 1990
13. Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ: Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neuro-surg 66:865-874, 1987
14. Kreisl TN: Chemotherapy for malignant gliomas. Semin Ra-diat Oncol 19:150-154, 2009
15. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190-198, 2001
16. Lang FF, Sawaya R, Suki D, McCutcheon IE, Hess KR: Glio-blastoma resection. J Neurosurg 116:1166-1167, author reply 1167-1168, 2012
17. Leifer D, Moore T, Ukena T, Wilner D, Thor A, Hedley-Whyte ET: Multifocal glioblastoma with liver metastases in the absence of surgery. Case report. J Neurosurg 71:772-776, 1989
18. Liwnicz BH, Rubinstein LJ: The pathways of extraneural spread in metastasizing gliomas: a report of three cases and critical review of the literature. Hum Pathol 10:453-467, 1979
19. Marko NF, Weil RJ, Schroeder JL, Lang FF, Suki D, Sawaya RE: Extent of resection of glioblastoma revisited: personal-ized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery. J Clin Oncol 32:774-782, 2014
20. Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS: An extent of resection threshold for newly diagnosed glio-blastomas. J Neurosurg 115:3-8, 2011
21. Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, Shi WM, et al: Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neu-rosurgery 42:1044-1056, 1998
22. Stummer W, Tonn JC, Mehdorn HM, Nestler U, Franz K, Goetz C, et al: Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article. J Neurosurg 114:613-623, 2011
23. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ: Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60:166-193, 2010
24. Vertosick FT Jr, Selker RG: Brain stem and spinal metastases of supratentorial glioblastoma multiforme: a clinical series. Neurosurgery 27:516-522, 1990
25. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG: Pat-terns of failure following treatment for glioblastoma multi-forme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16:1405-1409, 1989
26. Wilson CB: Glioblastoma: the past, the present, and the fu-ture. Clin Neurosurg 38:32-48, 1992
27. Yung WA, Horten BC, Shapiro WR: Meningeal gliomatosis: a review of 12 cases. Ann Neurol 8:605-608, 1980
28. Zinn PO, Mahajan B, Sathyan P, Singh SK, Majumder S, Jolesz FA, et al: Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme. PLoS One 6:e25451, 2011 (Erratum in PLoS One 7:10.1371/anno-tation/b5267cb3-6aa7-47fc-a648-47f30a7cff3e, 2013)